Event JSON
{
"id": "1a5bf03c2f752eb91d330dd4ba4ef9f3c6b9d3af43aa8f190558770ed379b2cf",
"pubkey": "6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"created_at": 1745662424,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/amcham-china-president-says-pharma-095706981.html"
],
[
"subject",
"US business lobby in China: Some pharma firms reporting tariff exemptions"
],
[
"published_at",
"1745575026"
],
[
"image",
"https://media.zenfs.com/en/reuters-finance.com/9bb6b9cc0ef2cde0e8353579b84728b7"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/reuters-finance.com/9bb6b9cc0ef2cde0e8353579b84728b7"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"The Beijing-based American Chamber of Commerce reported that some pharmaceutical companies have been able to import drugs with tariff exemptions over the past week. This move could be a sign that Chinese authorities are willing to be flexible to try to mitigate the impact of the ongoing US-China trade war. Big pharmaceutical companies including AstraZeneca, GSK, Johnson \u0026 Johnson, and Merck have manufacturing sites in the US for drugs sold in China. The tariff exemptions are reportedly drug-specific and not sector-wide, and companies are being asked to provide investment commitments in return."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqvap2usgr7nawhqexfk247ap0nfs34jqpjrxqqslrkv3rrrx8aesst3mr8r\nhttps://media.zenfs.com/en/reuters-finance.com/9bb6b9cc0ef2cde0e8353579b84728b7\n\nhttps://finance.yahoo.com/news/amcham-china-president-says-pharma-095706981.html",
"sig": "68cf52d92d155061b1d7fbfca45eff0540f80969e5e1631e841bedd93e76ad2f5dc5ea7d80c61dd0f90a56a9d453984ff295aed6aba2d2c5757e27186960a470"
}